Diversified Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $249K | Sell |
1,154
-112
| -9% | -$21.4K | ﹤0.01% | 984 |
|
|
2026
Q1 | $232K | Buy |
+1,266
| New | +$233K | ﹤0.01% | 924 |
|
|
2025
Q1 | – | Sell |
-22,926
| Closed | -$3.51M | – | 940 |
|
|
2024
Q4 | $3.51M | Buy |
22,926
+143
| +0.6% | +$24.1K | 0.09% | 140 |
|
|
2024
Q3 | $4.42M | Sell |
22,783
-73
| -0.3% | -$15.3K | 0.11% | 108 |
|
|
2024
Q2 | $5.3M | Buy |
22,856
+1,996
| +10% | +$434K | 0.15% | 82 |
|
|
2024
Q1 | $4.5M | Buy |
20,860
+9,588
| +85% | +$2.25M | 0.14% | 86 |
|
|
2023
Q4 | $2.92M | Buy |
+11,272
| New | +$2.77M | 0.1% | 114 |
|
|
2023
Q2 | – | Sell |
-1,103
| Closed | -$307K | – | 838 |
|
|
2023
Q1 | $307K | Sell |
1,103
-1,105
| -50% | -$306K | 0.01% | 612 |
|
|
2022
Q4 | $611K | Sell |
2,208
-163
| -7% | -$46K | 0.03% | 376 |
|
|
2022
Q3 | $633K | Buy |
+2,371
| New | +$504K | 0.03% | 312 |
|
|
2022
Q2 | – | Sell |
-1,485
| Closed | -$313K | – | 763 |
|
|
2022
Q1 | $313K | Buy |
1,485
+370
| +33% | +$80.5K | 0.01% | 601 |
|
|
2021
Q4 | $268K | Sell |
1,115
-274
| -20% | -$70.5K | 0.01% | 677 |
|
|
2021
Q3 | $393K | Hold |
1,389
| – | – | 0.01% | 482 |
|
|
2021
Q2 | $481K | Sell |
1,389
-131
| -9% | -$39.7K | 0.02% | 408 |
|
|
2021
Q1 | $425K | Sell |
1,520
-221
| -13% | -$59.6K | 0.02% | 429 |
|
|
2020
Q4 | $426K | Sell |
1,741
-239
| -12% | -$61.7K | 0.02% | 404 |
|
|
2020
Q3 | $562K | Buy |
1,980
+678
| +52% | +$189K | 0.03% | 287 |
|
|
2020
Q2 | $348K | Buy |
1,302
+143
| +12% | +$43K | 0.02% | 341 |
|
|
2020
Q1 | $367K | Buy |
+1,159
| New | +$352K | 0.02% | 265 |
|
|
2016
Q3 | – | Sell |
-2,596
| Closed | -$628K | – | 289 |
|
|
2016
Q2 | $628K | Sell |
2,596
-219
| -8% | -$57.7K | 0.07% | 214 |
|
|
2016
Q1 | $733K | Sell |
2,815
-73
| -3% | -$19.3K | 0.08% | 198 |
|
|
2015
Q4 | $885K | Sell |
2,888
-956
| -25% | -$275K | 0.09% | 189 |
|
|
2015
Q3 | $1.12M | Sell |
3,844
-1,101
| -22% | -$364K | 0.12% | 175 |
|
|
2015
Q2 | $2M | Hold |
4,945
| – | – | 0.19% | 135 |
|
|
2015
Q1 | $2.09M | Hold |
4,945
| – | – | 0.18% | 132 |
|
|
2014
Q4 | $1.68M | Buy |
+4,945
| New | +$1.6M | 0.15% | 160 |
|
|
2014
Q2 | $1.84M | Buy |
+5,835
| New | +$1.76M | 0.15% | 167 |
|
|
2013
Q4 | $1.6M | Sell |
5,725
-400
| -7% | -$103K | 0.16% | 118 |
|
|
2013
Q3 | $1.48M | Buy |
6,125
+1,590
| +35% | +$356K | 0.16% | 134 |
|
|
2013
Q2 | $976K | Buy |
+4,535
| New | +$969K | 0.12% | 181 |
|
Other funds holding BIIB
AIM
AAMU
ECSS
ADEF
Diversified Trust's BIIB Position: Q2 2026 in Review
Diversified Trust reduced its Biogen (BIIB) stake by 8.8% in Q2 2026, selling an estimated $21.4K and leaving 1,154 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #984.
Diversified Trust first reported a position in BIIB in Q2 2013 and has held it in 30 quarters since. The position peaked at $5.3M in Q2 2024. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Diversified Trust held 1,154 shares of Biogen worth $249K as of Q2 2026.
- Diversified Trust sold 112 Biogen shares in Q2 2026, an estimated $21.4K.
- Biogen made up ﹤0.01% of Diversified Trust's portfolio in Q2 2026, its #984 holding.
- Diversified Trust first reported a position in Biogen in Q2 2013 and has held it in 30 quarters since.
- Diversified Trust's Biogen position peaked at $5.3M in Q2 2024.
- 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.